Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology
PDL 1 immunohistochemistry laboratory validation
Date
07 Oct 2016Session
Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathologyPresenters
Mogens VybergAuthors
M. VybergAuthor affiliations
- Institute Of Pathology, Aalborg University Hospital, 9000 - Aalborg/DK
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
Introduction
Presenter: Peter Schirmacher
Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology
Resources:
Slides
Webcast
PDL 1 Immunohistochemistry clinical validation with the example of thoracic tumours
Presenter: Solange Peters
Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology
Resources:
Slides
Webcast
Beyond immunohistochemistry
Presenter: Ian Cree
Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology
Resources:
Slides
Webcast
Conclusions and clinical perspectives
Presenter: Rolf A. Stahel
Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology
Resources:
Webcast